Parkinson’s Disease: Available Clinical and Promising Omics Tests for Diagnostics, Disease Risk Assessment, and Pharmacotherapy Personalization

Parkinson’s disease is the second most frequent neurodegenerative disease, representing a significant medical and socio-economic problem. Modern medicine still has no answer to the question of why Parkinson’s disease develops and whether it is possible to develop an effective system of prevention. T...

Descripción completa

Detalles Bibliográficos
Autores principales: Trifonova, Oxana P., Maslov, Dmitri L., Balashova, Elena E., Urazgildeeva, Guzel R., Abaimov, Denis A., Fedotova, Ekaterina Yu., Poleschuk, Vsevolod V., Illarioshkin, Sergey N., Lokhov, Petr G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7277996/
https://www.ncbi.nlm.nih.gov/pubmed/32466249
http://dx.doi.org/10.3390/diagnostics10050339

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7277996/
https://www.ncbi.nlm.nih.gov/pubmed/32466249
http://dx.doi.org/10.3390/diagnostics10050339

Ejemplares similares